Published in RNA Biol on January 01, 2015
APOBEC1 complementation factor (A1CF) is not required for C-to-U RNA editing in vivo. RNA (2017) 0.75
An efficient method to enrich for knock-out and knock-in cellular clones using the CRISPR/Cas9 system. Cell Mol Life Sci (2017) 0.75
Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem (2007) 6.92
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst (1977) 6.91
RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell (2002) 5.14
Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science (1993) 3.52
Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science (2002) 3.04
Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc Natl Acad Sci U S A (1995) 2.80
Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Res (2005) 2.43
Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. Mol Cell (2008) 2.39
A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev (1997) 2.28
RNA editing by base deamination: more enzymes, more targets, new mysteries. Trends Biochem Sci (2001) 2.26
Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol Cell Biol (2000) 2.10
An in vitro system for the editing of apolipoprotein B mRNA. Cell (1989) 2.07
Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs. Nat Struct Mol Biol (2011) 2.04
The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem (1993) 1.93
Sequence requirements for the editing of apolipoprotein B mRNA. J Biol Chem (1991) 1.66
Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol (2009) 1.64
Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J Biol Chem (2000) 1.60
The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay. EMBO J (2003) 1.42
The ADAR protein family. Genome Biol (2012) 1.39
In vitro deamination of cytosine to uracil in single-stranded DNA by apolipoprotein B editing complex catalytic subunit 1 (APOBEC1). J Biol Chem (2003) 1.35
Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases. Front Microbiol (2013) 1.33
Sequence requirements for apolipoprotein B RNA editing in transfected rat hepatoma cells. J Biol Chem (1989) 1.33
Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor. J Biol Chem (2001) 1.32
Apobec-1 interacts with a 65-kDa complementing protein to edit apolipoprotein-B mRNA in vitro. J Biol Chem (1996) 1.28
Multiple protein domains determine the cell type-specific nuclear distribution of the catalytic subunit required for apolipoprotein B mRNA editing. Proc Natl Acad Sci U S A (1997) 1.28
Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA. J Biol Chem (1988) 1.28
Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. J Biol Chem (1991) 1.26
Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing. J Biol Chem (2000) 1.24
Three distinct RNA sequence elements are required for efficient apolipoprotein B (apoB) RNA editing in vitro. Nucleic Acids Res (1992) 1.22
The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing. Nucleic Acids Res (1996) 1.21
Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing. J Biol Chem (1996) 1.14
A sequence-specific RNA-binding protein complements apobec-1 To edit apolipoprotein B mRNA. Mol Cell Biol (1998) 1.14
Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing. RNA (2002) 1.11
Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity. J Biol Chem (2001) 1.11
Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice. J Biol Chem (1997) 1.11
Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1. J Biol Chem (2000) 1.08
A novel nuclear localization signal in the auxiliary domain of apobec-1 complementation factor regulates nucleocytoplasmic import and shuttling. J Biol Chem (2003) 1.07
A high-throughput screen to identify enhancers of ADAR-mediated RNA-editing. RNA Biol (2013) 1.04
Creative deaminases, self-inflicted damage, and genome evolution. Ann N Y Acad Sci (2012) 1.03
NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor. RNA (2005) 1.03
APOBEC-1-mediated RNA editing. Wiley Interdiscip Rev Syst Biol Med (2010) 1.02
Expression of apolipoprotein B mRNAs encoding higher- and lower-molecular weight isoproteins in rat liver and intestine. Proc Natl Acad Sci U S A (1989) 1.02
A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. J Biol Chem (2001) 1.00
Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J Biol Chem (1996) 0.99
Apolipoprotein B mRNA editing. Validation of a sensitive assay and developmental biology of RNA editing in the rat. J Biol Chem (1990) 0.99
Secondary structure for the apolipoprotein B mRNA editing site. Au-binding proteins interact with a stem loop. J Biol Chem (1998) 0.99
Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function. Mol Biol Evol (2010) 0.94
The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions. Wiley Interdiscip Rev RNA (2014) 0.94
Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice. Cancer Res (2007) 0.92
Inhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexes. Biol Chem (1998) 0.92
The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas. Genome Biol (2014) 0.91
Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a component of apobec-1 editosome. Biochem Biophys Res Commun (2001) 0.91
Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF. RNA (2004) 0.90
Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity. Exp Cell Res (1999) 0.89
Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor. Nucleic Acids Res (2006) 0.89
ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components. Am J Physiol Gastrointest Liver Physiol (2006) 0.89
C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47. EMBO Rep (2014) 0.89
Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver. Genome Biol (2014) 0.89
Measuring editing activity and identifying cytidine-to-uridine mRNA editing factors in cells and biochemical isolates. Methods Enzymol (2007) 0.88
Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization. J Lipid Res (1999) 0.85
Apolipoprotein expression and cellular differentiation in Caco-2 intestinal cells. Am J Physiol (1992) 0.85
Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits. J Lipid Res (1996) 0.84
Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing. J Biol Chem (2003) 0.84
Hypermutation of ApoB mRNA by rat APOBEC-1 overexpression mimics APOBEC-3 hypermutation. J Mol Biol (2012) 0.83
Processive DNA demethylation via DNA deaminase-induced lesion resolution. PLoS One (2014) 0.83
Calcium increases apolipoprotein B mRNA editing. Biochem Biophys Res Commun (2000) 0.81
APOBEC-1 complementation factor (ACF) forms RNA-dependent multimers. Biochem Biophys Res Commun (2010) 0.80
Editing of apolipoprotein B messenger RNA in differentiated Caco-2 cells. J Lipid Res (1990) 0.80
Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing. Biochem J (2001) 0.79
Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker. J Biol Chem (2002) 0.78
Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Res (2005) 2.43
Guidelines for naming nonprimate APOBEC3 genes and proteins. J Virol (2008) 1.86
The p75 neurotrophin receptor interacts with multiple MAGE proteins. J Biol Chem (2002) 1.13
Insights into DNA deaminases. Nat Struct Mol Biol (2007) 1.07
Analysis of reptilian APOBEC1 suggests that RNA editing may not be its ancestral function. Mol Biol Evol (2010) 0.94
The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas. Genome Biol (2014) 0.91
Optimal functional levels of activation-induced deaminase specifically require the Hsp40 DnaJa1. EMBO J (2011) 0.85